SCHEMBL2931006

SCHEMBL2931006

Cc1cc(Cc2cc(C)c(C(C)(C)C)cc2O)c(O)cc1C(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.50
▸ ALOX15 P16050 6/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.50
▸ CYP1A2 P05177 3/20 0.50
▸ HSPA5 P11021 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ ATP2A2 P16615 1/20 0.50
▸ ATP2A3 Q93084 1/20 0.50
▸ CYP2C9 P11712 6/20 0.48
▸ CYP2C19 P33261 5/20 0.48
▸ HIF1A Q16665 5/20 0.48
▸ CYP2D6 P10635 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ TP53 P04637 4/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TYR P14679 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405765 1.00 ALDH1A1 (0.50) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL9154600 0.88 ALOX15 (0.50) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL9054498 0.85 SMN1; SMN2 (0.56) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL12733114 0.83 ALOX15 (0.68) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL27482806 0.82 HMGCR (0.46) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL28052258 0.81 GABRA1 (0.44) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL23542362 0.80 ALOX15 (0.62) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL28795591 0.80 TYR (0.47) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL13310903 0.79 CYP2C9 (0.56) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5
SCHEMBL3628725 0.78 ALOX15 (0.68) ALDH1A1ALOX15SMN1; SMN2CYP1A2HSPA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1908786-B1 2-CYANOACRYLATE COMPOSITION TOAGOSEI CO LTD (JP) 2010-09-15 — — EP claimed
US-20240400815-A1 METHODS OF CURING COMPOSITIONS BASED ON MULTISTAGE POLYMERS ARKEMA FRANCE (FR) 2024-12-05 — — US disclosed
US-12084571-B2 Curable compositions based on multistage polymers ARKEMA FRANCE (FR) 2024-09-10 — — US disclosed
WO-2023112417-A1 METHOD FOR PRODUCING POLY(PHENYLENE ETHER) 太陽ホールディングス株式会社 2023-06-22 — — WO disclosed
US-11638950-B2 Articles prepared using curable compositions based on polymerizable ionic species ARKEMA FRANCE (FR) 2023-05-02 — — US disclosed
US-11597002-B2 — — 2023-03-07 — — US disclosed
US-20220273547-A1 NAIL COATINGS BASED ON PHOTOCURABLE COMPOSITIONS ARKEMA FRANCE (FR) 2022-09-01 — — US disclosed
EP-4004059-A1 NAIL COATINGS BASED ON PHOTOCURABLE COMPOSITIONS ARKEMA FRANCE (FR) 2022-06-01 — — EP disclosed
US-20210171760-A1 CURABLE COMPOSITIONS BASED ON MULTISTAGE POLYMERS ARKEMA FRANCE (FR) 2021-06-10 — — US disclosed
EP-3823772-A1 ARTICLES PREPARED USING CURABLE COMPOSITIONS BASED ON POLYMERIZABLE IONIC SPECIES ARKEMA FRANCE (FR) 2021-05-26 — — EP disclosed
US-6022928-A CROSSLINKED SULFONATED STYRENE-CONJUGATED DIENE COPOLYMER HAVING A WEIGHT AVERAGE MOLECULAR WEIGHT OF 900,000 OR MORE SONY CORPORATION (JP) 2000-02-08 — — US disclosed
EP-0505202-B1 Stabilized polyacetal compositions DU PONT (US) 1996-02-28 — — EP disclosed
EP-0505202-A1 Stabilized polyacetal compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-23 — — EP disclosed
US-5149723-A Heat and ultraviolet light resistant; hindered amine light stabilizers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-22 — — US disclosed
US-4888371-A HEAT RESISTANCE, LIGHT RESISTANCE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-12-19 — — US disclosed
EP-0155847-A2 A stabilizer for synthetic resins and resins stabilized thereby SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-09-25 — — EP disclosed
US-4420341-A OXIDATION RESISTANCE, PLASTICS FERRIGNO THOMAS H 1983-12-13 — — US disclosed
US-4388362-A LEUCO DYE AND ACID, ULTRAVIOLET SETTING INK, PRESSURE SENSITIVE ADHESIVE RICOH CO., LTD. (JP) 1983-06-14 — — US disclosed
US-4223147-A POLYMER STABILIZERS BAYER AKTIENGESELLSCHAFT (DE) 1980-09-16 — — US disclosed
US-4051312-A SULFUR VULCANIZABLE INTERPOLYMERS EXXON RESEARCH & ENGINEERING CO. (US) 1977-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220273547-A1 NAIL COATINGS BASED ON PHOTOCURABLE COMPOSITIONS NACA, PIK3C3, POLR1C ALDH1A1 1119/4885ALOX15 4074/4885SMN1; SMN2 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback